High-Dose Anticoagulation May Not Aid COVID-19 Patients
No significant benefit seen for high-dose versus standard anticoagulation therapies, may be harmful
Physician’s Briefing Weekly Coronavirus Roundup
AI Model May Predict Immunotherapy Response in Melanoma
Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma
AHA: Adding Omega-3 Fatty Acids Does Not Cut High CV Risk
No reduction seen in CV events with omega-3 versus corn oil in addition to usual background therapies, including statins
U.S. COVID-19 Deaths Top a Quarter Million
COVID-19 cases on the rise in all but one state
Disproportionality Signal Found for Suicidality in Finasteride Users
Younger patients and those with alopecia have significant disproportionality signals for increased suicidality
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Vitamin D Supplementation Tied to Reduction in Advanced Cancer
On stratification by BMI, significant reduction found in incident metastatic or fatal cancer in normal weight, not overweight/obese
Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater
